Feb 17 (Reuters) - Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell short of the market’s revenue expectations in Q4 CY2025, but ...

Labcorp (NYSE:LH) executives said the company delivered what CEO Adam Schechter called a “very strong year” in 2025, citing ...

Labcorp (LH) stock dips as the company posts mixed Q4 2025 financials, falling short of Street forecasts for revenue while ...

Q4 2025 Management View CEO Adam Schechter stated that 2025 was a strong year with "over 7% top line growth, 13% adjusted EPS growth and with margins also improving by over 50 basis points." He ...

Burlington, North Carolina-based Labcorp Holdings Inc. (LH) provides laboratory services that help doctors, hospitals, ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test ...

Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or ...

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...

The earnings results for Labcorp Hldgs (NYSE: LH) for Q4 were made public on Tuesday, February 17, 2026 at 06:50 AM. Here's a ...